1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Gemini BioProducts, LLC

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

1985

Location

West Sacramento CA US

Primary Industry

Biotechnology

About

Founded in 1985 and based in California, US, Gemini BioProducts, LLC is a biotechnology company that provides biological products and chemical reagents such as antibiotics and antimycotics, amino acids, culture supplements, recombinant proteins, and albumins, for the academic research, biotechnology, cell and gene therapy, and biopharmaceutical sectors.
Current Investors
BelHealth Investment Partners

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals
Website
www.gembio.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only

Deals

Deals Type
Trade Sale
Private Debt
Add-on
Buyout
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Gemini BioProducts, LLC 27 Oct 2022
Completed Gemini BioProducts, LLC 04 Nov 2021
Completed E.I. Spectra, LLC 11 Nov 2019
Completed Gemini BioProducts, LLC 14 Sep 2018
Displaying 1-4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.